Humane Cosmetics Act of 2023
The enactment of HB 5399 is poised to have a considerable impact on state laws related to cosmetic testing. It would not only reduce reliance on animal models for testing but also impact how cosmetic safety is assessed. No evidence from post-enactment animal testing would be permitted to establish the safety of cosmetics under the Federal Food, Drug, and Cosmetic Act unless it met specific exemptions. This could catalyze a shift towards alternative testing methods and further research into humane practices in the cosmetics field.
House Bill 5399, titled the 'Humane Cosmetics Act of 2023', aims to significantly restrict the use of animal testing in the cosmetics industry. Under this bill, beginning one year after enactment, it would be unlawful to conduct or contract cosmetic animal testing in the United States. Additionally, corporations would be prohibited from selling or transporting any cosmetic product developed using animal testing performed after this date. This bill reflects a growing concern for animal welfare and aims to promote humane practices within the cosmetics sector.
While the bill has garnered support due to its alignment with animal welfare objectives, there are points of contention. Manufacturers may argue about the feasibility of replacing animal testing in some contexts, especially if no alternatives are deemed sufficient by federal standards. Concerns have been raised about the potential impact on product safety assessments and whether this could lead to unforeseen risks based on reliance on alternative methods that may evolve under the bill's provisions.